How many patients with metastatic liver cancer have successful surgeries?

The success rate of surgery for metastatic liver cancer depends on various factors, including the extent of the disease, the location and size of the tumors, the patient's overall health, and the surgical approach used.

In general, surgical resection (removal) of liver metastases can be considered for patients with a limited number of tumors that are confined to the liver and have not spread to other organs. The aim of surgery is to remove all visible tumors and achieve complete resection, which can potentially lead to long-term survival or even a cure.

According to medical research and studies, the success rates of liver metastasectomy (surgical removal of liver metastases) vary widely depending on the specific circumstances of each patient. Here are some general estimates:

1. For patients with colorectal liver metastases: The success rates of liver metastasectomy range from 20% to 50%, meaning that about 20-50% of patients experience long-term survival after complete surgical resection. The success rates depend on factors such as the number and location of metastases, the patient's overall health, and the surgical technique used.

2. For patients with liver metastases from other primary cancers (such as breast cancer, lung cancer, or melanoma): The success rates of liver metastasectomy tend to be lower compared to colorectal liver metastases, ranging from 10% to 30%. This is because these metastases are often more aggressive and may be more difficult to resect completely.

It's important to note that these are general estimates and individual patient outcomes can vary significantly. Factors such as the expertise of the surgical team, the patient's overall health, and access to advanced medical care can influence the success rates of liver metastasectomy.

The decision to proceed with surgery for metastatic liver cancer is complex and requires careful evaluation by a multidisciplinary team of healthcare professionals, including liver surgeons, oncologists, and other specialists. They consider the patient's individual circumstances, the extent of the disease, and the potential benefits and risks of surgery to determine the best course of treatment.